Mesenchymal stem cells in the treatment of severe COVID-19
Transl Med Commun
.
2021;6(1):16.
doi: 10.1186/s41231-021-00095-0.
Epub 2021 Aug 9.
Authors
Santosh Kesari
1
2
,
Gregory C Kasper
3
,
Lev Verkh
4
,
Terese C Hammond
5
,
Marla L Matal
3
,
Jay W Hammerling
3
,
Nikolai Tankovich
4
,
Adrianus P Lim
3
,
Kevin H Zhao
3
,
Tiffany Juarez
1
,
Roberta E Redfern
3
,
Jaya M Gill
6
,
Natsuko Nomura
1
,
Audrey Hiemer
1
,
Annie Heng
1
,
Jessica Shoemaker
3
Affiliations
1
Pacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USA.
2
University of California San Diego Health System, Translational Neurosciences and Neurotherapeutics, Santa Monica, CA 90404 USA.
3
ProMedica Toledo Hospital, 2142 North Cove Blvd, Toledo, OH 43606 USA.
4
Stemedica Cell Technologies, Inc., San Diego, USA.
5
Providence Saint John's Health Center, Santa Monica, USA.
6
Pacific Neuroscience Institute, Santa Monica, USA.
PMID:
34395912
PMCID:
PMC8350555
DOI:
10.1186/s41231-021-00095-0
No abstract available